The current study suggests that TSP-1 mimetic peptides similar to properdistatin may be developed to therapeutic drugs for patients with malignant melanoma, and that such treatment may improve vascular function and increase the uptake of therapeutic drugs. Here, THBS1 is linked to melanoma.